tiprankstipranks
Trending News
More News >
Matex International Limited (SG:M15)
SGX:M15
Singapore Market

Matex International Limited (M15) AI Stock Analysis

Compare
0 Followers

Top Page

SG:M15

Matex International Limited

(SGX:M15)

Select Model
Select Model
Select Model
Underperform 37 (OpenAI - 4o)
Rating:37Underperform
Price Target:
S$0.02
▲(5.00% Upside)
Matex International Limited faces significant financial challenges, with declining revenues and persistent losses. Technical analysis indicates a lack of momentum and potential overbought conditions. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield. These factors collectively result in a low overall stock score.
Positive Factors
Leadership Strengthening
The appointment of a new Executive Director and CTO can enhance technical leadership and drive innovation, potentially improving product offerings and competitive positioning.
Strategic Governance Changes
Aligning board structure with regulatory standards can improve governance and strategic decision-making, potentially enhancing investor confidence and operational stability.
Sustainable Product Focus
Emphasis on sustainable solutions can attract eco-conscious clients and command premium pricing, supporting long-term revenue growth and market differentiation.
Negative Factors
Declining Revenue
Consistent revenue decline indicates challenges in maintaining market share and demand, potentially impacting long-term financial health and operational viability.
Profitability Challenges
Ongoing profitability issues suggest difficulty in cost management and pricing power, which could hinder the company's ability to reinvest in growth and innovation.
Cash Flow Weakness
Weak cash flow generation limits financial flexibility and the ability to fund operations and strategic initiatives, posing risks to long-term sustainability.

Matex International Limited (M15) vs. iShares MSCI Singapore ETF (EWS)

Matex International Limited Business Overview & Revenue Model

Company DescriptionMatex International Limited engages in the formulation, manufacture, and sale of specialty chemicals in Singapore, the People's Republic of China, and Malaysia. It offers dyestuffs, auxiliaries, textile chemicals, and optical brighteners, as well as color measurement and computer aided systems. The company is also involved in the import, export, and wholesale of garments, textile products, and chemical products, as well as general wholesale activities. In addition, it engages in the manufacture and repair of measuring devices, process control equipment, and other related products. The company serves textile, paper, leather, detergent, and polymer industries. Matex International Limited was incorporated in 1989 and is headquartered in Singapore.
How the Company Makes MoneyMatex International Limited generates revenue through the sale of its specialty chemical products and solutions to various industries. The company's primary revenue streams include direct sales to textile manufacturers, partnerships with distributors, and agreements with key industry players that enhance its market reach. Additionally, Matex focuses on developing innovative and sustainable chemical solutions, which allows it to command premium pricing and attract clients seeking eco-friendly options. The company's commitment to research and development also leads to strategic collaborations that drive additional revenue through the introduction of new product lines tailored to emerging market needs.

Matex International Limited Financial Statement Overview

Summary
Matex International Limited is experiencing significant financial challenges, with declining revenues and persistent losses impacting its income statement. The balance sheet shows moderate leverage and a strong equity ratio, but the negative return on equity underscores profitability concerns. Cash flow remains a critical issue, with negative operating cash flow and inconsistent free cash flow growth.
Income Statement
35
Negative
Matex International Limited has experienced declining revenue over the years, with a negative revenue growth rate of -7.19% in the TTM period. The company is facing significant profitability challenges, as evidenced by negative net profit margins and EBIT margins. The gross profit margin is relatively low at 21.56%, indicating limited pricing power or high cost of goods sold. Overall, the income statement reflects a struggling financial performance with consistent losses.
Balance Sheet
45
Neutral
The balance sheet shows a moderate debt-to-equity ratio of 0.18 in the TTM period, suggesting manageable leverage levels. However, the return on equity is negative, indicating that the company is not generating returns for its shareholders. The equity ratio stands at 65.15%, which is a positive sign of financial stability. Despite these strengths, the negative ROE highlights ongoing profitability issues.
Cash Flow
40
Negative
Cash flow analysis reveals a negative operating cash flow, indicating that the company is not generating sufficient cash from its core operations. The free cash flow to net income ratio is above 1, suggesting that the company is managing its cash flow better than its net income would imply. However, the overall cash flow position remains weak, with negative free cash flow growth in prior periods.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue6.06M7.00M7.35M14.59M20.93M24.63M
Gross Profit1.31M1.47M1.61M2.51M2.64M3.42M
EBITDA-4.33M-2.55M-3.23M5.39M-5.01M-8.58M
Net Income-3.53M-2.65M-3.31M7.27M-4.93M-6.38M
Balance Sheet
Total Assets16.90M15.24M21.40M24.25M30.22M33.52M
Cash, Cash Equivalents and Short-Term Investments10.09M8.86M16.37M11.92M5.66M4.51M
Total Debt1.98M1.49M3.20M4.40M6.12M11.83M
Total Liabilities7.13M7.29M9.15M9.15M23.14M19.59M
Stockholders Equity11.02M9.05M12.70M14.88M7.80M12.53M
Cash Flow
Free Cash Flow-3.51M-2.97M-754.00K-1.25M-35.00K-4.67M
Operating Cash Flow-2.94M-2.40M-456.00K-1.17M238.00K-3.98M
Investing Cash Flow-2.89M-3.23M3.82M11.77M-267.00K-578.00K
Financing Cash Flow6.95M-1.88M1.12M-4.82M1.91M5.65M

Matex International Limited Technical Analysis

Technical Analysis Sentiment
Negative
Last Price0.02
Price Trends
50DMA
0.02
Negative
100DMA
0.02
Negative
200DMA
0.02
Negative
Market Momentum
MACD
>-0.01
Neutral
RSI
100.00
Negative
STOCH
>-0.01
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:M15, the sentiment is Negative. The current price of 0.02 is below the 20-day moving average (MA) of 0.02, below the 50-day MA of 0.02, and below the 200-day MA of 0.02, indicating a bearish trend. The MACD of >-0.01 indicates Neutral momentum. The RSI at 100.00 is Negative, neither overbought nor oversold. The STOCH value of >-0.01 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SG:M15.

Matex International Limited Peers Comparison

Overall Rating
UnderperformOutperform
Sector (61)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
S$29.16M4.7714.32%1.25%33.55%2595.24%
61
Neutral
$10.43B7.12-0.05%2.87%2.86%-36.73%
60
Neutral
S$16.16M12.783.08%-8.21%
46
Neutral
S$39.87M-1.86-19.55%1.03%-7.45%-480.22%
45
Neutral
S$55.68M-2.37-20.85%-2.43%52.80%
37
Underperform
S$11.35M-2.47-31.32%-20.15%-2.30%
* Basic Materials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:M15
Matex International Limited
0.02
0.00
0.00%
SG:C05
Chemical Industries Far East Ltd.
0.48
0.02
4.35%
SG:5DS
MegaChem Ltd.
0.42
0.00
0.00%
SG:5MD
Soon Lian Holdings Limited
0.24
0.05
26.32%
SG:C8R
Jiutian Chemical Group Limited
0.03
>-0.01
-7.14%
SG:N32
Nippecraft Limited
0.05
<0.01
2.17%

Matex International Limited Corporate Events

Matex International Announces Board Re-designation
Nov 26, 2025

Matex International Limited, a company incorporated in Singapore, has announced a change in its Board of Directors. Mr. James Kho Chung Wah, currently an Independent Director, will be re-designated as the Independent Chairman of the Board effective 26 November 2025. Despite this change, the company acknowledges its current non-compliance with certain corporate governance rules and aims to address these issues by filling board and committee vacancies within three months.

Matex International Faces Significant Legal Expenditure Impact
Nov 17, 2025

Matex International Limited, a company incorporated in Singapore, has announced a significant legal expenditure of S$518,942.41 incurred over a 10-week period related to shareholder requisitions, lawsuits, and a settlement agreement. This expenditure represents approximately 93.5% of the company’s gross profit for the first half of 2025 and 5.3% of its net assets as of June 30, 2025. The Board is currently assessing the financial impact and seeking legal advice on the reasonableness of these expenses.

Matex International Faces Legal Demand Over Settlement Payments
Nov 11, 2025

Matex International Limited, a company incorporated in Singapore, has received a letter of demand from Dr Tan Pang Kee and Mr Tan Guan Liang regarding cessation payments due under a settlement agreement. The letter demands payment by 18 November 2025, failing which legal action will be initiated. The company is seeking legal advice and will update shareholders as necessary.

Matex International Announces Major Board Reshuffle
Nov 6, 2025

Matex International Limited, a company incorporated in Singapore, has announced significant changes to its board and board committees, effective from November 5, 2025. The company appointed Mr. Chen Hongbo as the new CEO, while Dr. Danny Oh Beng Teck, Mr. Tan Chong Huat, and Mr. Yeo Hock Huat have resigned from their respective positions. These changes are seen as an opportunity for the company to reassess the size and composition of its board and committees, aligning with the Code of Corporate Governance 2018 and the Catalist Rules. The company plans to fill the vacancies within three months.

Matex International Plans EGM for Cessation Payments Approval
Nov 3, 2025

Matex International Limited has announced an update regarding its intended Extraordinary General Meeting (EGM) to seek shareholder approval for cessation payments to Dr Tan Pang Kee and Mr Tan Guan Liang. The Board plans to publish the notice for the EGM by December 19, 2025, aiming to hold the meeting in January 2026. The payments are classified as an ‘interested person transaction’ under Catalist Rules, and the company is working with legal advisors to ensure all relevant information is provided to shareholders.

Matex International Limited Announces Board Changes
Oct 16, 2025

Matex International Limited, a company incorporated in Singapore, has announced a change in its board of directors with the appointment of Dr. Liu Shen as Executive Director and Chief Technical Officer, effective from October 17, 2025. This appointment reflects the company’s strategic decision to strengthen its leadership team, although Dr. Liu Shen will not be part of any board committees, leaving the current committee compositions unchanged.

Matex International Limited Holds Extraordinary General Meeting
Oct 15, 2025

Matex International Limited held an Extraordinary General Meeting at the Suntec Singapore Convention & Exhibition Centre. The meeting was briefly adjourned to await announcements to the Singapore Exchange Securities Trading Limited, after which it resumed. The meeting introduced directors and proposed nominated directors, highlighting the company’s ongoing governance and strategic planning efforts.

Matex International Announces Board Restructuring
Sep 29, 2025

Matex International Limited, a company incorporated in Singapore, has announced changes to its board and board committees effective from September 30, 2025. Mr. Tan Chong Huat has been re-designated as Non-Executive Independent Chairman and Chairman of the Remuneration Committee, while Mr. Chng Hee Kok and Mr. James Kho Chung Wah have also undergone re-designations within the board structure. These changes reflect the company’s efforts to align with the Catalist Rules of the Singapore Exchange Securities Trading Limited, potentially impacting its governance and strategic decision-making processes.

Matex International Concludes Lawsuits, Trading Suspension Continues
Sep 26, 2025

Matex International Limited, a company incorporated in Singapore, announced the discontinuance of two lawsuits, OA 733 and OA 790, following a court hearing and judgment. The court indicated that an injunction against the Subscription Agreements would have been granted if OA 733 had not been discontinued due to non-compliance with the company’s constitution. The trading suspension of the company’s securities remains in effect, and stakeholders are advised to stay informed through future announcements.

Matex International Terminates Subscription Agreements
Sep 22, 2025

Matex International Limited has announced the termination of its subscription agreements with Ms. Lim Yan Peng and Ms. Gan Peiling, which were initially intended for the subscription of new shares in the company. This decision, made with the consent of all parties involved, will not result in any new share allotment or issuance, and no liabilities or obligations will arise from these agreements. The termination is not expected to materially impact the company’s net tangible assets or earnings per share for the financial year ending December 2025. The company’s trading suspension, effective since July 2025, remains in place, and stakeholders are advised to stay informed through further announcements.

Matex International Settles Leadership Changes with Key Resignations
Sep 19, 2025

Matex International Limited has entered into a settlement agreement involving the resignation of Dr. Tan Pang Kee and Mr. Tan Guan Liang from their positions within the company. The agreement includes financial settlements and non-compete clauses, and it also involves the termination of subscription agreements with Ms. Gan Peiling and Ms. Lim Yan Peng. This settlement is expected to impact the company’s operational dynamics and stakeholder relationships, potentially stabilizing its governance structure and market positioning.

Matex International Announces Board Restructuring
Sep 16, 2025

Matex International Limited, a company incorporated in Singapore, has announced significant changes to its board and board committees, effective from September 16, 2025. The company has appointed Mr. Tan Chong Huat as the Non-Executive Non-Independent Chairman and Dr. Danny Oh Beng Teck as an Executive Director. Additionally, Mr. James Kho Chung Wah has been re-designated as Lead Independent Director, and Mr. Chng Hee Kok has been re-designated as the Chairman of the Remuneration Committee. These changes are expected to impact the company’s governance structure and strategic direction.

Matex International Cancels Extraordinary General Meeting Amid Legal Developments
Sep 10, 2025

Matex International Limited has announced the cancellation of an extraordinary general meeting initially scheduled for September 11, 2025, due to developments in a legal matter identified as HC/OA 790/2025. The company’s securities remain suspended from trading since July 23, 2025, and stakeholders are advised to stay informed through further announcements.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025